Trials / Completed
CompletedNCT06009172
APA on Sleep Quality in Women With PCOS
The Effect of Auricular Point Acupressure on Sleep Quality in Women With Polycystic Ovary Syndrome:A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- The First Affiliated Hospital of Xiamen University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Women with polycystic ovary syndrome (PCOS) appear to have an increased frequency of sleep problems. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS.
Detailed description
Polycystic ovary syndrome (PCOS) is a prevalent disorder affecting 5-18% of reproductive-age women. In recent years, women with PCOS appear to have an increased frequency of sleep problems, and the prevalence of poor sleep in PCOS is high at 31%. The aim of this study was to explore the effect of auricular point acupressure (APA) pressure on sleep quality in women with PCOS. We verified the effect of APA pressure on sleep quality, quality of life, anxiety level, sex hormone indexes, and biochemical indexes in two groups after the intervention. So as to provide a sleep management strategy in PCOS women for future clinical practice guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Auricular point acupressure (APA) | Auricular point acupressure (APA) is a method derived from Traditional Chinese Medicine. PCOS women in the APA group began to apply pressure on the first day of enrollment. Patients were instructed to press each acupuncture point 3 times a day for 30 times. The PCOS woman is then trained to go to the outpatient clinic every 5-7 days to change the auricular acupressure sticker. The intervention period was 4 weeks. |
Timeline
- Start date
- 2022-07-24
- Primary completion
- 2023-06-01
- Completion
- 2023-07-31
- First posted
- 2023-08-24
- Last updated
- 2023-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06009172. Inclusion in this directory is not an endorsement.